Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study.

Vincent-Salomon, A; MacGrogan, G; Couturier, J; Arnould, L; Denoux, Y; Fiche, M; Jacquemier, J; Mathieu, M-C; Penault-Llorca, F; Rigaud, C; Roger, P; Treilleux, I; Vilain, M-O; Mathoulin-Pélissier, S; Le Doussal, V

Vincent-Salomon, A; MacGrogan, G; Couturier, J; Arnould, L; Denoux, Y; Fiche, M; Jacquemier, J; Mathieu, M-C; Penault-Llorca, F; Rigaud, C; Roger, P; Treilleux, I; Vilain, M-O; Mathoulin-Pélissier, S; Le Doussal, V.

Affiliation

Vincent-Salomon A; Institut Curie, Paris, France. anne.salomon@curie.net

Histopathology ; 42(4): 337-47, 2003 Apr.

Article in En | MEDLINE | ID: mdl-12653945

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Immunohistochemistry / Adenocarcinoma / Receptor, ErbB-2 / Genes, erbB-2 Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Histopathology Year: 2003 Document type: Article Affiliation country: Francia Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links